Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 10;57(12):2772-2789.e8.
doi: 10.1016/j.immuni.2024.11.006. Epub 2024 Nov 28.

Interleukin-2-secreting T helper cells promote extra-follicular B cell maturation via intrinsic regulation of a B cell mTOR-AKT-Blimp-1 axis

Affiliations

Interleukin-2-secreting T helper cells promote extra-follicular B cell maturation via intrinsic regulation of a B cell mTOR-AKT-Blimp-1 axis

Caterina E Faliti et al. Immunity. .

Abstract

During antigen-driven responses, B cells can differentiate at extra-follicular (EF) sites or initiate germinal centers (GCs) in processes that involve interactions with T cells. Here, we examined the roles of interleukin (IL)-2 secreted by T helper (Th) cells during cognate interactions with activated B cells. IL-2 boosted the expansion of EF plasma cells and the secretion of low-mutated immunoglobulin G (IgG). Conversely, genetically disrupting IL-2 expression by CD4+ T cells, or IL-2 receptor (CD25) expression by B cells, promoted B cell entry into the GC and high-affinity antibody secretion. Mechanistically, IL-2 induced early mTOR activity, expression of the transcriptional regulator IRF4, and metabolic changes in B cells required to form Blimp-1-expressing plasma cells. Thus, T cell help via IL-2 regulates an mTOR-AKT-Blimp-1 axis in activated B cells, providing insight into the mechanisms that determine EF versus GC fates and positioning IL-2 as an early switch controlling plasma cell versus GC B cell commitment.

Keywords: CD4 T cells; IL-2 cytokine; T follicular helper cells; Tfh cells; antibodies; mTOR; metabolism; plasma cells; vaccine.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.C. has consulted for GSK, JP Morgan, Citi, Morgan Stanley, Avalia NZ, Nutcracker Therapeutics, University of California, California State Universities, United Airlines, Adagio, Sanofi, and Roche. W.R.S. is inventor on patent applications related to immunogens in this manuscript filed by Scripps and IAVI. W.R.S. is an employee of Moderna, Inc. S.B. is a current employee of VIR Biotechnology and may possess shares of VIR Biotechnology.

References

    1. Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dörner T, and Hiepe F (2006). Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 6, 741–750. 10.1038/nri1886. - DOI - PubMed
    1. Slifka MK, Antia R, Whitmire JK, and Ahmed R (1998). Humoral immunity due to long-lived plasma cells. Immunity 8, 363–372. 10.1016/s1074-7613(00)80541-5. - DOI - PubMed
    1. Victora GD, and Nussenzweig MC (2022). Germinal Centers. Annu Rev Immunol 40, 413–442. 10.1146/annurev-immunol-120419-022408. - DOI - PubMed
    1. Elsner RA, and Shlomchik MJ (2020). Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity. Immunity 53, 1136–1150. 10.1016/j.immuni.2020.11.006. - DOI - PMC - PubMed
    1. Abbott RK, Lee JH, Menis S, Skog P, Rossi M, Ota T, Kulp DW, Bhullar D, Kalyuzhniy O, Havenar-Daughton C, et al. (2018). Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens. Immunity 48, 133–146.e136. 10.1016/j.immuni.2017.11.023. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources